Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00916383 · ClinicalTrials.gov registry record · Phase 2
Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System
A Phase 2 study, sponsored by Teikoku Pharma USA.
- Completed
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT00916383 is a Phase 2 study that has completed, run by Teikoku Pharma USA. The registered enrollment target is 49 participants.
The verdict
NCT00916383, a Phase 2 study, has completed, sponsored by Teikoku Pharma USA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
This study is designed to assess skin tolerability, skin irritation, and adhesion of the 350 mg Donepezil Transdermal Patch (DTP-system), following 3, 7-day applications to 3 specific areas of the body (upper back, upper middle arm, side of torso) of elderly Alzheimer's patients. The total application time for the DTP-system is 21 days.
Interventions
- DRUG Placebo Patch
- DRUG 350 mg Donepezil Transdermal Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2009-05 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00916383
The ClinicalTrials.gov registry entry for NCT00916383 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teikoku Pharma USA, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.
NCT00916383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00916383 about?
NCT00916383 is a clinical study titled "Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System". This study is designed to assess skin tolerability, skin irritation, and adhesion of the 350 mg Donepezil Transdermal Patch (DTP-system), following 3, 7-day applications to 3 specific areas of the body (upper back, upper middle arm, side of torso) of elderly Alzheimer's patients. The total applicati...
What is the current status of trial NCT00916383?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2009-05. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00916383?
The interventions under investigation include: Placebo Patch (DRUG), 350 mg Donepezil Transdermal Patch (DRUG).
Who is sponsoring clinical trial NCT00916383?
This trial is sponsored by Teikoku Pharma USA, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.